Dublin-based Atreon Orthopedics develops synthetic electrospun scaffolds and biologic-support devices for musculoskeletal and tissue healing. A privately owned start-up built on more than 17 years of research and development, the company’s Autobiologic™ platform is designed to work with the body’s own healing factors, with ROTIUM® used at the tendon-bone interface and related solutions extending into wound reconstruction. Atreon’s growing intellectual property portfolio includes more than 50 issued and pending patents, and its FDA-cleared ROTIUM technology has been used in more than 12,000 rotator cuff procedures.
FDA 510(k) clearance for ROTIUM
registration
FDA 510(k) clearance for BioCharge
registration